The DOI matches its Crossref record.
Mocarhagin, a Novel Cobra Venom Metalloproteinase, Cleaves the Platelet von Willebrand Factor Receptor Glycoprotein Ibα. Identification of the Sulfated Tyrosine/Anionic Sequence Tyr-276−Glu-282 of Glycoprotein Ibα as a Binding Site for von Willebrand Factor and α-Thrombin
Abstract
Platelet adhesion to the subendothelium is the initiating event in hemostasis and thrombosis and involves the binding of von Willebrand factor (vWF) by the platelet membrane glycoprotein (GP) Ib-IX complex. The alpha-chain of GP Ib contains binding sites for both vWF and alpha-thrombin within a 45-kDa N-terminal tryptic fragment. In the present study, we have further delineated these sites using smaller proteolytic fragments and functional antibodies. Mocarhagin, a cobra venom metallaproteinase, generates the fragment His-1-Glu-282, while cathepsin G, a neutrophil granule serine protease, generates a slightly smaller fragment, His-1-Leu-275. His-1-Glu-282 was as effective as intact soluble GP Ibalpha (glycocalicin) in inhibiting botrocetin-dependent binding of vWF to washed platelets (IC50 approximately 0.3 microM) whereas His-1-Leu-275 was an order of magnitude less effective (IC50 approximately 3 microM). Residues Tyr-276-Glu-282 (YDYYPEE) are part of an anionic region homologous to thrombin-binding molecules such as hirudin. In ligand blot analysis, thrombin blotted the His-1-Glu-282 fragment, but not His-1-Leu-275. The three tyrosine residues within Tyr-276-Glu-282 meet the consensus criteria for O-sulfation. A method was developed to distinguish O-sulfated from nonsulfated tyrosine residues based on differences in the UV absorbance spectra. Residues Tyr-276-Glu-282 were isolated from glycocalicin by proteolysis with mocarhagin and cathepsin G. Ion spray mass spectrometry confirmed that Tyr-278 and Tyr-279 was only approximately 50% O-sulfated. Four anti-GP Ibalpha monoclonal antibodies (SZ2, ES85, C34 and VM16d) were found to be modulator-specific, strongly inhibiting botrocetin-dependent binding of vWF, but having less or no effect on ristocetin-dependent vWF binding. These antibodies also inhibited the binding of thrombin to fixed platelets. Immunoprecipitation with GP ibalpha fragments defined the epitopes for these antibodies as SZ2 (Tyr-276-Glu-282), ES85 (Asp-283-Arg-293), C34 (His-1-Glu-282), and VM16d (His-1-Leu-275). An antibody which inhibited ristocetin-dependent, as well as botrocetin-dependent, vWF binding but had no effect on thrombin binding (Ak2) had an epitope within His-1-Leu-275. These findings indicate that the sulfated tyrosine/anionic GP Ibalpha residues Tyr-276-Glu-282 are important for the binding of thrombin and botrocetin-dependent binding of thrombin and the botrocetin-dependent binding of vWF, but that vWF also interacts with residues within His-1-Leu-275.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Platelet-neutrophil-interactions: Linking hemostasis and inflammation
Zarbock, A., Polanowska-Grabowska, R. K., & Ley, K. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.06.001 · Cited by 651
Platelet Glycoprotein Ibα Is a Counterreceptor for the Leukocyte Integrin Mac-1 (Cd11b/Cd18)
Simon, D. I., Chen, Z., Xu, H., Li, C. Q., Dong, J.-F., McIntire, L. V., Ballantyne, C. M., Zhang, L., Furman, M. I., Berndt, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.193 · Cited by 581
Self-citationLópez, J. A., Andrews, R. K., Afshar-Kharghan, V., & Berndt, M. C. (1998) · Blood · doi:10.1182/blood.v91.12.4397 · Cited by 560
Self-citationSulfonation and molecular action
Strott, C. A. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0040 · Cited by 487
Snake venom proteases affecting hemostasis and thrombosis
Matsui, T., Fujimura, Y., & Titani, K. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00268-x · Cited by 475
The Clearance Mechanism of Chilled Blood Platelets
Hoffmeister, K. M., Felbinger, T. W., Falet, H., Denis, C. V., Bergmeier, W., Mayadas, T. N., von Andrian, U. H., Wagner, D. D., Stossel, T. P., & Hartwig, J. H. (2003) · Cell · doi:10.1016/s0092-8674(02)01253-9 · Cited by 441
The Biology and Enzymology of Protein Tyrosine O-Sulfation
Moore, K. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300008200 · Cited by 360
The Glycoprotein Ib-IX-V Complex Is a Platelet Counterreceptor for P-Selectin
Romo, G. M., Dong, J.-F., Schade, A. J., Gardiner, E. E., Kansas, G. S., Li, C. Q., McIntire, L. V., Berndt, M. C., & López, J. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.803 · Cited by 355
Self-citationAndré, P., Denis, C. V., Ware, J., Saffaripour, S., Hynes, R. O., Ruggeri, Z. M., & Wagner, D. D. (2000) · Blood · doi:10.1182/blood.v96.10.3322 · Cited by 308
A Stimulatory Role for cGMP-Dependent Protein Kinase in Platelet Activation
Li, Z., Xi, X., Gu, M., Feil, R., Ye, R. D., Eigenthaler, M., Hofmann, F., & Du, X. (2003) · Cell · doi:10.1016/s0092-8674(02)01254-0 · Cited by 265
Tyrosine sulfation: a modulator of extracellular protein–protein interactions
Kehoe, J. W., & Bertozzi, C. R. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00093-4 · Cited by 259
Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation
Mandel, J., Casari, M., Stepanyan, M., Martyanov, A., & Deppermann, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073868 · Cited by 253
Haemostatically active proteins in snake venoms
Sajevic, T., Leonardi, A., & Križaj, I. (2011) · Toxicon · doi:10.1016/j.toxicon.2011.01.006 · Cited by 252
Gardiner, E. E., De Luca, M., McNally, T., Michelson, A. D., Andrews, R. K., & Berndt, M. C. (2001) · Blood · doi:10.1182/blood.v98.5.1440 · Cited by 72
Self-citation
Metadata
- Authors
- Ward, C. M., Andrews, R. K., Smith, A. I., & Berndt, M. C.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1996-01-01
- Volume
- 35
- Issue
- 15
- Pages
- 4929-4938
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2066463869
- Cited by
- 177
- References
- 0
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.